NEW YORK (Reuters Health) – In patients with atrial fibrillation, strict heart rate control provides no advantage over more lenient control, according to a focused update of the…
NEW YORK (Reuters Health) – Spironolactone use is associated with improved long-term survival in patients with systolic heart failure, researchers from Japan report in the December American Heart…
NEW YORK (Reuters Health) – In a prospective study, the beta-1 selective blocker bisoprolol proved more effective than the non-selective beta-blocker carvedilol in preventing atrial fibrillation after coronary…
NEW YORK (Reuters Health) – Smoking does not affect outcomes after early clopidogrel use in patients with acute coronary syndrome (ACS), according to findings published in the November…
NEW YORK (Reuters Health) – The management of heart failure guided by an individualized target level of N-terminal pro-B-type natriuretic peptide (NT-proBNP) doesn’t lead to clinically significant improvements…
NEW YORK (Reuters Health) – In the short term, cryoablation for atrioventricular nodal reentrant tachycardia (AVNRT) is as effective as radiofrequency catheter ablation, but 6-month recurrence rates are…
NEW YORK (Reuters Health) – Elevated systolic blood pressure and low diastolic blood pressure are associated with increased risk of cardiovascular disease (CVD) among patients with type 2…
NEW YORK (Reuters Health) – In high-risk post-acute coronary syndrome (ACS) patients, a J- or U-shaped association exists between blood pressure and the risk of future cardiovascular events,…
NEW YORK (Reuters Health) – Family history, age, cholesterol and blood pressure levels, and conditions such as diabetes remain the mainstay of assessing the risk of cardiovascular disease…
NEW YORK (Reuters Health) – Forget those headlines from the past few years linking hypercholesterolemia in midlife to risk of dementia in old age. Data presented in the…